Biographical Sketch
Eloy Villasuso III, MD, is an Otolaryngologist at Cleveland Clinic Florida in Weston. His clinical interests include hearing loss, dizziness/balance disorders, chronic ear infections, pediatric ear disease, acoustic neuromas, lateral skull base tumors, facial nerve disorders, cochlear implants and otosclerosis.
Dr. Villasuso received his medical degree from the University of Miami School of Medicine in Miami, Fla. He completed an otolaryngology residency at the University of Miami/Jackson Memorial Hospital, and he completed an otology, neurotology, and skull base surgery fellowship at the Michigan Ear Institute in Farmington Hills, Mich. He is licensed to practice medicine in Michigan and Florida.
Dr. Villasuso has written a number of articles and abstracts that have appeared in peer-reviewed publications. He is a member of the AmericanAcademyof Otolaryngology/Head and Neck Surgery, the North American Skull Base Society, the American Neurotology Society and the Otosclerosis Study Group.
Industry Relationships
Cleveland Clinic physicians and scientists report if they
have any collaborations with the pharmaceutical or medical
device industries as part of the Cleveland Clinic’s
procedures. The Cleveland Clinic publicly discloses
payments to its physicians and scientists for speaking and
consulting of $5,000 or more per year, and any equity,
royalties, and fiduciary relationships in companies with
which they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its doctors’
connections with industry and those of their immediate
family members. As of 2/24/2010,
Dr. Villasuso III has reported no financial relationship with
industry that is applicable to this listing. Patients
should feel free to contact their doctor about
relationships with industry and how the relationships are
overseen by the Cleveland Clinic. To learn more about
the Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to our
Integrity in Innovation page.
